Similarly, EFV-mediated PXR activation alters hepatic lipogenic gene expression and is responsible for EFV-induced hepatic steatosis, liver damage and hypercholesterolemia in mice, as mice with liver-specific PXR deletion do not display these effects when treated with EFV [92]. The gene discussed is NR1I2; the disease is Hypercholesterolemia.